INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Corporate insider
HC

Harmon Cyrus

DirectorCIK 0001831410

EDGAR filingsOpen in network
Disclosed transactions4
Buys / sells0 / 3
Max Insider Score40
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
11
HC
Harmon CyrusDirector
OLMAOlema Pharmaceuticals, Inc.
Grant or award
A—
29.5K sh
Jun 18, 2026Jun 23, 2026
traded Jun 18, 2026
+5dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Olema Pharmaceuticals, Inc.Director · Dec 29, 2025
33
HC
Harmon CyrusDirector
OLMAOlema Pharmaceuticals, Inc.
Open-market sale
SELL
$269K
10.0K sh
Jan 20, 2026
Jan 21, 2026
traded Jan 20, 2026
+1d
SEC FORM 4

Evidence

30
HC
Harmon CyrusDirector
OLMAOlema Pharmaceuticals, Inc.
Open-market sale
SELL$102K
3,489 sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC FORM 4

Evidence

40
HC
Harmon CyrusDirector
OLMAOlema Pharmaceuticals, Inc.
Open-market sale
SELL$82K
2,881 sh
Dec 22, 2025Dec 29, 2025
traded Dec 22, 2025
+7dSEC FORM 4

Evidence